SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " clinical " 975 found 🔀 AI-powered Shuffle
Tag Team Approaches Helping Earn Wins for Mental Healthcare
By Yanet Luna, Vitals contributor Nearly one in seven California adults experiences a mental health condition. Yet close to two-thirds of those individuals do not receive the needed care, according to a 2022 report by the California Health Care Foundation. Clinical teams, community organizations and mental health advocates across the country understand the importance of creative […]
Beware the risks of ‘wellness’ peptides
The peptide craze is replacing rigorous clinical trials with unfettered self-experimentation.
Dr. Alexander Chiu Awarded UW Health Rising Star Clinical Practice Award
Dr. Alexander Chiu, assistant professor in the Division of Endocrine Surgery, was awarded the UW Health Rising Star Clinical Practice Award at the Physician Excellence Awards Reception on May 20. The UW Health Rising Star …
NYC Health + Hospitals System Chief Medical Officer for Clinical Services and Population Health Dr. Ted Long Receives 2026 Sloan Public Service Award - NYC Health + Hospitals
New York, NY — NYC Health + Hospitals and the Fund for the City of New York today announced that Ted Long, MD, MHS, Senior Vice President, System Chief
Neuroinfectious Diseases Research Workshop: Advancing Translational Science and Clinical Research Innovation
The Neuroinfectious Diseases Research Workshop will be a two-day scientific meeting designed to accelerate research, foster collaboration, and build capacity in the field of neurological infections. Hosted at the NIH Neuroscience Center (NSC, Executive Boulevard), this meeting will bring together clinician-scientists, laboratory investigators, translational researchers, government partners, and trainees committed to advancing understanding of neuroinfectious
California advances $12 billion bond for science research in rebuke to Trump cuts
UCSF researchers say the bond could help protect studies, jobs and clinical trials from delays in federal NIH funding
New depression treatment targets the immune system instead of the brain
A surprising new approach to depression treatment is showing early promise — not by targeting brain chemicals, but by calming the immune system. In a small clinical trial, researchers found that an anti-inflammatory drug normally used for rheumatoid arthritis appeared to ease symptoms in people with hard-to-treat depression, while also reducing fatigue and anxiety and improving quality of life.
Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC
/PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically...
Australia introduces advanced course on clinical safety in digital health and more briefs
Also, New Zealand is seeking providers of AI-powered mammography solutions to support BreastScreen Aotearoa.
Meet the 2026–2027 Dhablania and Kim Family Global Medicine and Health Fellows
Seven students and trainees have been awarded 2026–2027 Dhablania and Kim Family Global Medicine and Health Fellowships through the Department of Population and Public Health Sciences at the Keck School of Medicine of USC. Thanks to generous support from the Dhablania and Kim Family, this year’s cohort will pursue research and clinical projects in India, Cambodia, South Korea, Peru and Uganda, engaging in cross-cultural learning while gaining firsthand experience with global health issues.
Learning Health System holds 7th annual symposium
Co-sponsors of the Learning Health System (LHS) Symposium held May 14 at the Vanderbilt Student Life Center join keynote speaker Kevin High, MD, MS, (second from right), a leader in academic LHS for Charlotte, N.C.-based Advocate Health. From left are Christiane Roumie, MD, MPH, Director of the U.S. Department of Veterans Affairs VETWISE-LHS Center of Innovation, Cheryl Gatto, PhD, and Matthew Semler, MD, MSCI, from the Center for Learning Healthcare of the Vanderbilt Institute for Clinical and Translational Research, and, at far right, symposium Chair Sunil Kripalani, MD, MSc, Director of the Vanderbilt Center for Health Services Research. (photo by Susan Urmy) Recipients of the Operational Partner Award were honored at the May 14 Learning Health System (LHS) Symposium for their efforts, in partnership with the LHS academic initiative, to improve frontline patient care at Vanderbilt Health and the U.S. Department of Veterans Affairs Tennessee Valley Healthcare System. (photo by Susan Urmy)
Banner Health report shows Arizona research driving national medical innovation
Milestones in Research details 1,300 clinical and translational research studies, FDA-approved heart device, landmark Alzheimer's prevention work Dr Wilber Su Wilber Su, MD, cardiologist for Banner Health, in the operating room. Phoenix, May 26, 2026 (GLOBE NEWSWIRE) -- Banner Health's $80.5 million research enterprise delivered breakthrough treatments to Arizona patients in 2025 while advancing wide-ranging therapies toward FDA approval, according to the organization's annual Milestones in Rese
Aspira Women’s Health and Cleveland Clinic Expand Strategic Collaboration to Advance AI-Powered Diagnostics in Women’s Health
Collaboration aims to accelerate biomarker discovery, strengthen translational research capabilities, and support scalable clinical validation
New Ebola Vaccine Reportedly Nearing Clinical Trials (Live Updates)
The vaccine, which hasn’t been tested on humans, would be the first capable of treating the deadly Bundibugyo strain of Ebola.
Watch Lilly Gets Back Into the Vaccine Business With New Deals
Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion as it looks to become a leader in infectious diseases. The drugmaker has been using cash from its obesity drugs to expand into other disease areas. Bloomberg's Gerry Smith reports.
Advancing Global Sports Medicine Through Two Strategic Collaborations
Cleveland Clinic’s Global Peak Performance Center and PGA TOUR partnership pair advanced assessment with longitudinal follow-up to enhance clinical decision-making.
Advancing Global Sports Medicine Through Two Strategic Collaborations
Cleveland Clinic’s Global Peak Performance Center and PGA TOUR partnership pair advanced assessment with longitudinal follow-up to enhance clinical decision-making.
Precision Medicine’s Next Hurdle Isn’t Science
A new UPMC report found that while most health systems now offer precision medicine programs, many still face challenges scaling them due to reimbursement, data integration and patient engagement issues. Health system leaders say the field’s future depends on embedding genomics into routine care, as well as proving its clinical and financial value.
How integrating tradition and self-care has strengthened public health in the Americas
On 13 May 2026, a regional dialogue for the Americas titled, Innovative Experiences to Strengthen Health and Self-Care through Traditional, Complementary, and Integrative Medicine, was hosted by EsSalud, the government agency responsible for social security and health care in Peru.The event brought together representatives from the World Health Organization (WHO), the Pan American Health Organization (PAHO), WHO collaborating centres, the health sector and academia. It presented regional perspectives from BrBolivia, Brazil, Mexico and Peru to explore how self-care and traditional medicine can strengthen public health, empower communities and support more inclusive models of care. Across all four countries, a clear message emerged: traditional medicine is not being positioned as an alternative to formal systems, but as a way to strengthen them. In the Americas region, the challenge is to consolidate intercultural and holistic care, with the aim of strengthening the healthcare system – making care more preventive, culturally relevant and community-based.Peru: institutionalizing complementary care over 28 years Dr Martha Villar López from EsSalud Peru demonstrated how integration can be institutionalized over time. With nearly three decades of investment, including a research programme dating back to 1998, traditional medicine is now embedded within public health infrastructure. EsSalud’s flagship programme, Reforma de Vida, operating as Prevenir, takes multidisciplinary teams into workplaces to reduce and detect risk factors for chronic noncommunicable diseases. Education cycles are structured around three pillars: celestial nourishment, focused on life purpose and movement; terrestrial nourishment, centred on regional food and healthy diets; and human nourishment, addressing identity, relationships, stress and spirituality. Grounded in Andean cosmovision and the principle of the ayllu, the programme aligns with local cultural values. Since 2007, it has trained over 6600 health leaders, certified more than 3100 health-friendly organizations and built alliances with nearly 11 000 employers.Bolivia: legal recognition and medical pluralism Adelino Pau Carpacheco, an 82-year-old Callawaya healer, described working with more than 220 medicinal plants, supported by deep generational knowledge. Traditional healers and plant medicine are highly respected in the country. Bolivia’s contribution also highlighted the role of policy in enabling integration. Through Law 459, traditional medicine has been formally recognized within a legal framework and led the country to medical pluralism where traditional medicine coexists with biomedicine, and both are now offered free of charge through the public health system. Mexico: preserving Indigenous knowledge and reinventing food culture Mexico presented two complementary approaches focused on knowledge preservation and food systems. In Veracruz, communities partnered with a university to safeguard Totonac traditional medicine through a diploma programme launched in 2019. This collaboration has already produced practical outputs, including manuals and a dictionary, helping to sustain knowledge at risk due to migration and generational change. Alongside this, Dr Hernán García, Directorate of Traditional Medicine and Intercultural Development – Mexico, explained how the Dieta de la Milpa programme addresses Mexico’s dual burden of malnutrition and rising noncommunicable diseases. Rooted in traditional Mayan cultivation systems and ingredients, it promotes healthier diets through community-led, intercultural approaches involving local authorities, Indigenous leaders and cooks. By reconnecting food, culture and health, it offers a practical pathway to prevention. Brazil: community therapy as a public health tool Brazil’s experience centred on Integrative Community Therapy, a methodology developed over 40 years ago by Dr Adalberto Barreto and now used in more than 47 countries. Therapy circles create spaces where participants share experiences and coping strategies, building social support networks at very low cost. Within Brazil’s Unified Health System, the approach has expanded rapidly since its inclusion in national policy in 2017. By 2025, more than five million integrative practice procedures were delivered annually in primary care, with registrations for this therapy increasing by over 500% in eight years. The main challenge now is equity, with access still concentrated in urban areas such as São Paulo. A shared regional direction against a global backdrop Drawing these experiences together, Dr Natalia Aldana of the TCIM Network of the Americas highlighted the shared outcomes of the interventions discussed. Such approaches strengthen healthy behaviours, social networks and community resilience; they are low-cost, adaptable and enable active participation in care, while showing potential to reduce the burden of noncommunicable diseases.The regional momentum mirrors a broader global shift. Dr João Paulo Souz, Director of BIREME (Latin American and Caribbean Center on Health Sciences Information), the specialized center of PAHO/WHO, emphasized that the Global Traditional Medicine Strategy 2025–2034 promotes a vision centred on people, evidence and integrated use. He noted that health should be understood through the relationships between people, community, nature and spirituality. Self-care interventions as a critical pathway towards universal health coverage Dr Manjulaa Narasimhan, Unit Head for Sexual Health and Well-being across the Life-course at WHO, delivered a presentation titled Advancing Self-Care in Traditional Medicine: Aligning the WHO Traditional Medicine Strategy 2025–2034 with the WHO Self-Care Framework, co-authored by Dr Geetha Krishnan Gopalakrishna Pillai, Unit Head for Research, Data and Innovation at the WHO Global Traditional Medicine Centre. WHO recommends self-care interventions for every country and economic setting as a critical path to reach universal health coverage – and traditional medicine acts as a bridge for self-care. Dr Narasimhan explained that traditional medicine contributes most effectively to self-care when embedded directly into primary health care, not operating in parallel, siloed systems. This, she stated, “is possibly the only sustainable way to deliver continuity of care that meets the needs, rights and priorities of communities and individuals”. The Global Traditional Medicine Strategy 2025–2034 is a move towards a more people-centred approach to health care that champions holistic approaches to health equity and patient autonomy.The integration of traditional medicine and self-care requires collaboration across disciplines, clear referral pathways, trained health and care workers, and strong leadership that supports integration. The WHO self-care competency framework defines 10 key competencies for health and care workers to support self-care in their clinical practice, supported by the WHO guideline on self-care interventions for health and well-being. These documents help health-care workers safeguard their own well-being and ensure that care is consistent, safe and grounded in shared standards and values.Together, the discussion through this dialogue points to a fundamental shift in how health systems are designed in the region, and globally, towards models that are more inclusive, culturally-grounded and responsive to the needs of the communities they serve. It is a move towards a system where traditional medicine is respected and responsibly integrated, where self-care provides empowerment and evidence-based care, and where health systems are supportive rather than being distant from these systems.Traditional medicine perspectives from Bolivia, Mexico and Peru - WHO's "Restoring Balance" seriesInnovative Experiences to Strengthen Health and Self-Care through Traditional, Complementary, and Integrative Medicine was streamed in Spanish, with Spanish and Portuguese subtitles. Recordings are available through the CABSIN YouTube channel with Portuguese subtitles and on the BVS MTCI Americas YouTube channel with Spanish subtitles. Dr Narasimhan’s session can be watched in English on both channels.
'We can identify these really early, before the clinical diagnosis': Epigenetic markers may help explain why Native Hawaiians are aging faster
Live Science spoke with Alika Maunakea, an Native Hawaiian epigeneticist, about how epigenetics underpins health disparities between Native Hawaiians and others in Hawaii.
AI scans 400,000 Reddit posts and finds hidden Ozempic side effects
By analyzing over 400,000 Reddit posts, researchers discovered that users of popular GLP-1 weight-loss drugs frequently discussed unexpected symptoms like menstrual irregularities, chills, and hot flashes. The findings suggest AI could turn social media into a powerful early-warning system for spotting side effects that clinical trials may miss.
Licensing clinical AI like it’s a doctor: 3 medical leaders issue 6-step call
Among other attributes, the change would represent a solid upgrade over current FDA safety guardrails around AI-equipped medical devices. So say three thought leaders who are close watchers of medical ethics and technologies.
Bond breakout? Big effects of bad data. Immigration and thermostatic politics & dad-chat is coming for dad-books.
Thank you for opening your Chartbook email. Anna Airy, A Shell Forge at a National Projectile Factory, Hackney Marshes, London, 1918 Bond breakout - John Authers Across the developed markets, bond markets are staging a slow-motion car wreck. Looking at the drastic moves in the US, Japan, the UK and France, Barclays’ Ajay Rajadhyaksha commented: “Last week, long bonds broke. Not in one country. In all of them. Simultaneously. Four countries. Four different political systems. Four different central banks. But the same trade — “get me out of duration!”” Each country has its own contributing political problems, but the uniformity of the shift out of long-term bonds with high duration makes clear that something broader is afoot. For Rajadhyaksha, it is “simple and uncomfortable.” The developed world “has too much debt, too little fiscal discipline, and no political appetite for fixing either.” If there’s a trigger, it has been the Iran war and the resulting shock to oil supply. Source: Bloomberg G7 countries are now borrowing at rates that were enjoyed by EM in the early 2020s For contributing subscribers only. Subscribe Trade between China and Russia has grown in recent years For contributing subscribers only. Subscribe Big effects of bad data A decade ago nearly nine in ten Americans, when approached, agreed to fill out the Current Population Survey, which is administered to about 60,000 households each month and asks about, among other things, employment. Fewer than seven in ten do so now (see chart 1). For the Consumer Expenditure Survey, which tries to capture 3,700 households monthly, the response rate is down from 68% to 40%. … When the information becomes less reliable, investment decisions get more difficult to make. Some may be delayed, creating a potential drag on the economy. A new working paper by Nicholas Bloom of Stanford University, Erica Groshen, former head of the Bureau of Labour Statistics (BLS) now at Cornell University, and Duncan Hobbs and Michael Strain of the American Enterprise Institute, a think-tank, hazards an estimate. Preserving trust in “the integrity and quality of official statistics”, the authors claim, generates economic benefits of about $25 for every $1 spent on the BLS, the agency with an annual budget of $700m that is responsible for many of these data. To arrive at their conclusion the quartet analysed an ignoble episode in the BLS’s recent history. On August 1st 2025 Donald Trump sacked Erika McEntarfer, appointed as the agency’s commissioner by his predecessor, Joe Biden. The president alleged, without evidence, that the BLS’s steep downward revision to recent jobs numbers had been “RIGGED in order to make the Republicans, and ME, look bad”. In fact, it was the wanton dismissal that looked bad in the eyes of many observers. In the following seven days there was a 50% leap, relative to the week before, in the average value of the index of Economic Policy Uncertainty (EPU), which tracks the number of articles mentioning such uncertainty that are published daily in American newspapers. This was a discernible jump even when compared to the chaos caused by Mr Trump’s trade war in April 2025 and his real one in Iran in the past two months (see chart 2). Based on Mr Bloom’s earlier study with other colleagues of the EPU’s impact on business investment, industrial production and employment, the authors estimate that the jump reduced American GDP by over $100bn (0.3%) and non-farm payrolls by 168,000 (0.1%). Source: The Economist Immigration and thermostatic politics (Sarah O’Connor in the FT) A strange thing happened a year and a half ago. No sooner had Americans elected Donald Trump as president on an explicitly anti-immigration platform than US public opinion began to swing much more favourably towards immigration. … to political scientists who study “thermostatic” politics, this development is no surprise at all. Public opinion often moves against the prevailing party, especially if they are perceived to have gone “too far” in one direction. The phenomenon was first explored in the 1990s with reference to fiscal policy, but in recent years it has been particularly evident in the realm of immigration policy. While these swings in opinion polls can make it seem as if people don’t know their own minds, they can be a useful democratic check on governments by sending bright flashing warning lights when policies stray too far from the public’s comfort zone. The problem comes when politicians misinterpret those signals. When people tell pollsters they want less immigration, or think it is bad for the country overall (or the converse), they are often expressing an opinion about how things appear to be going in that moment relative to their preferences, rather than a deep shift in their underlying views. According to Alexander Kustov, a political scientist, most Americans’ views are quite stable and moderate: they support immigration that is controlled and in the national interest, and oppose flows that are disorderly or under-enforced. In the US, he argues the Trump administration over-interpreted dissatisfaction with high immigration under Joe Biden, and implemented policies that went too far for many voters. “People don’t necessarily change their idea about their ideal immigration policy, but they can react to what the government is currently doing,” he told me. “A lot of people are not happy with what the Trump administration are doing — right now we’re not talking about border enforcement, we’re talking about people not just getting harassed, but killed.” But similarly, he added, pro-immigration advocates would be making a mistake to interpret the recent, more favourable swing towards immigration as a deep-seated ideological shift in attitudes. The recent history of UK immigration policy offers another cautionary tale. After the 2016 Brexit referendum, public concern about immigration fell. This was partly because net migration statistics declined, but also because people felt a sense of catharsis and control, says Sunder Katwala, director of British Future, a think-tank. By 2019, the public ranked immigration as only the ninth biggest issue of concern, according to Ipsos polling. But when the Conservative government liberalised visa routes for students and care workers between 2019 and 2022, that helped net migration to surge. And so, too, did public concern. Today’s Labour government has implemented another sharply restrictive turn in immigration policy. As Kustov and researcher Caitlyn Yates argue, thermostatic public opinion should be a useful check on politicians. Instead it seems to have helped to magnify the pendulum swing in the UK. The government over-interprets and overreacts to a change in public opinion, which reacts in turn, prompting a sudden swing the other way. Source: Financial Times HEY READERS, THANK YOU for opening the Chartbook email. I hope it brightens your day. I enjoy putting out the newsletter, but tbh, what keeps this flow going is the generosity of those readers who clicked the subscription button. If you are persuaded to click, please consider the annual subscription of $50. It is both better value for you and a much better deal for me, as it involves only one credit card charge. Why feed the payments companies if we don’t have to. Subscribe Anna Airy, Shop for Machining 15-Inch Shells: Singer Manufacturing Company, Clydebank, Glasgow, 1918 Racing for a vaccine … we have been here before! The deadly Ebola outbreak in two African countries driven by a virus species with no vaccine has triggered an urgent search for a potential jab, in a test of troubled global efforts to avert threats posed by emerging diseases. A World Health Organization advisory group is due to would meet on Tuesday to recommend candidate jabs to prioritise for clinical trials, the global health body said. It will assess data including an analysis by the Coalition for Epidemic Preparedness Innovations (Cepi), which was set up after failures in the international response to a previous Ebola crisis. The latest Ebola outbreak in Democratic Republic of Congo and Uganda has infected hundreds of people and killed more than 80, health authorities say. Cepi’s reaction will be a crucial indicator of its progress towards its wider goal of producing vaccines for pandemic threats in just 100 days, despite steep cuts to international health funding. “If there was ever a time that we could show the world why Cepi is needed and show the world why the 100-day mission is needed, it’s now,” Nicole Lurie, the organisation’s executive director for preparedness and response, told the FT. “We’re happy to accept that responsibility, but obviously we need help from partners — particularly financial help in the long run.” DR Congo and Uganda would make the final decision on whether to press ahead with any vaccine candidates endorsed for clinical trials by the WHO experts, the global health body said. “Other ethical and community acceptability issues will be considered,” said the WHO, which declared the latest outbreak a public health emergency of international concern on Sunday. “This will be important to make sure that the trial, if it happens, will be adequately communicated to the population.” Lurie said Cepi had provided information from a survey of research teams and companies working on drugs that might be effective against the Bundibugyo virus behind the outbreak. The organisation hoped soon to announce partners in the quest for a jab, she added, although she declined to give a timescale for when one might be developed. Cepi’s Nicole Laurie said global health bodies were ‘getting some live-fire drills’ with hantavirus and the latest Ebola outbreak. The hunt for a vaccine should be helped by scientific advances including the use of artificial intelligence to find drugs active against viruses, Lurie said. Existing jabs against the Zaire Ebola virus responsible for many previous outbreaks might provide a basis for tackling the Bundibugyo species, she added. “We’ll see how far and how fast we can get,” Lurie said, adding that Cepi had done preliminary work recently on a possible jab for the rat-borne hantavirus responsible for a recent fatal outbreak on a cruise ship. “Both with hantavirus and now with Ebola, [we] are getting some live-fire drills.” Source: Michael Peel in the Financial Times Dad-chat is coming for dad-books. (By Pamela Paul and Jeffrey A. Trachtenberg in the WSJ) They were the go-to gifts for Father’s Day: a book about some little-known chapter of World War II, the sweeping narrative of a shipwreck, perhaps the latest presidential biography. These days, dad books are a dying breed. Nonfiction book sales have been in decline for the past four years, and are now the most challenged segment of the print book market. Publishers say certain types of books still fare well—including celebrity memoirs and religious titles. But in recent years, print sales in such categories as biography, current affairs and business and economics—what publishers refer to as “serious nonfiction” and which tend to resonate especially with men—have fallen considerably. Sales of nonfiction print titles were down nearly 8% through May 9 this year, and sales of books about politics and current affairs were down 19%, according to book tracker Circana BookScan. Publishing has long been subject to cyclical changes, with trends in format and genre taking over bookshelves in grand sweeps. (Remember the adult coloring-book craze? Or the stratospheric rise of romantasy?) But many in publishing believe the decline in serious nonfiction is more existential. “The trend couldn’t be clearer,” said Jonathan Karp, the former chief executive of Simon & Schuster and publisher of the new Simon Six imprint. “This is a sea change and people should wake up and realize we’re living in a new world.” One culprit for the shift: a new media diet for fans of more serious nonfiction. … Sixty-two percent of men and 54% of women consumed a podcast in the prior month, according to a recent survey by Edison Research at SSRS, up from 46% and 39%, respectively, in 2023. “When we have internal meetings to talk about this problem, it always comes around to podcasts,” said Jonathan Burnham, president and publisher of the Harper Group at HarperCollins Publishers. “The man who wants to read American history is now tuning into one of the many good podcasts about history that lends the quiet attention to a serious subject he’s looking for. It makes the idea of sitting down with a 700-page Ron Chernow book less appealing. You’ve scratched that itch.” Source: Wall Street Journal Remarkable report by Novara from the nationalist rally in London in mid May. Anna Airy, Leopard Moth and Plums, 1915 If you’ve scrolled this far, you know you want to click: Subscribe
How TAVR valve implant depth impacts clinical outcomes
TAVR procedures with a higher implant depth are associated with certain clinical benefits after one year, according to a new study of data from more than 600 patients.
Anavex Life Sciences Receives Expected Nasdaq Delinquency Notification
Anavex Life Sciences Corp. (“Anavex” or the “Company”)(Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders, today announced it received anexpected delinquency notification letter (the “Notice”) from the Listing QualificationsDepartment of The Nasdaq Stock Market LLC (“Nasdaq”) on May 20, 2026.
How the Clinical & Translational Science Institute at UCLA Health advances medicine from bench to bedside
Clinical trials are at the heart of UCLA Health’s Clinical & Translational Science Institute
Surprising study finds beef doesn’t worsen blood sugar or diabetes risk
A new clinical trial suggests that eating beef every day may not be as risky for people with prediabetes as many assume. Researchers found that adults who ate 6–7 ounces of beef daily for a month showed no worsening in blood sugar control, insulin function, inflammation, or other key markers linked to type 2 diabetes when compared to people eating poultry instead.
World Health Assembly endorses resolution on precision medicine
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on Precision medicine: a path towards targeted, personalized and equitable care, taking an important step towards advancing precision medicine as part of efforts to strengthen equitable, effective and sustainable health systems. Precision medicine refers to the use of clinical, molecular, genomic and other health data to inform prevention, diagnosis and treatment, taking into account variability while applying appropriate ethical and legal safeguards. When integrated responsibly into health systems, precision approaches can improve outcomes across different disease areas and across the life course – from cancer and rare diseases to infectious diseases, maternal, newborn and child health, mental health and noncommunicable diseases. The resolution reflects rapid advances in genomics, diagnostics, data science and digital health, alongside widening global inequities in access to these innovations. Many populations – particularly in low- and middle-income countries – remain underrepresented in data and research, limiting the public health impact of precision medicine and risking the widening of health disparities if action is not taken now. "Precision medicine is not an aspirational idea for health delivery in the future – it is already transforming lives across the world. But its benefits remain out of reach for too many and the research driving progress is concentrated in high income countries. This WHA resolution gives global health leaders, ministries of health, and WHO a clear mandate: to act. From infant screening to setting up genomic databases WHO will work with countries to bring about the power of these innovations." Dr Meg Doherty, Director Science for HealthThrough the resolution, Member States commit to developing and strengthening national policies, infrastructure, workforce capacity and governance frameworks to support the safe, ethical and equitable integration of precision medicine into health systems, aligned with universal health coverage. This includes promoting affordability, ensuring inclusive research and data systems, strengthening regulation and data governance, and fostering collaboration across sectors and regions.WHO is requested to provide technical and normative support, review and coordinate existing guidance, facilitate global and regional collaboration, and develop a Global Strategy on Precision Medicine to guide equitable and context‑appropriate implementation. WHO stands ready to support Member States through tools such as a country maturity model for countries to self-assess capacity in implementing precision medicine depending on their context. In the immediate term WHO will map all existing guidance and frameworks and host extensive consultations with interest holders globally.By placing equity, inclusion and public value at the centre of precision medicine, the resolution reinforces WHO’s commitment to ensuring that scientific advances benefit all people, everywhere, and that no one is left behind in the next era of health innovation."By uniting people-centered healthcare with innovation, precision medicine has the potential to transform lives. This resolution helps ensure those advances serve the shared goal of health for all." Dr Sylvie Briand, Chief Scientist For further information please visit the Health Topic: Genomics
A new sporting event’s controversial pitch: Performance-enhancing drugs welcome
The Enhanced Games, taking place this weekend in Las Vegas, support “safe, responsible, and clinically supervised use of performance enhancements.”
WHO Health Emergencies EPI-WIN webinar: Hantavirus in Focus II: hantavirus in an international maritime setting: natural history, infection control and clinical management of patients in hospital
Recent hantavirus cases associated with an international maritime setting have highlighted the complex and global nature of outbreak detection, clinical management, and public health response. This webinar will provide updates on the natural history of the disease, clinical management approaches, and response challenges.
New obesity drug helped patients lose up to 85 pounds in trial
A new experimental obesity drug from Eli Lilly helped patients lose an average of about 85 pounds in a late-stage clinical trial. Duke Health expert Dr. Susan Spratt says the results are reaching levels typically only seen with gastric bypass surgery.
Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call
NORWOOD, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage company focused on devel...
Narayana Institute of Cardiac Sciences becomes India's first HIMSS AMAM Stage 6 hospital
The organisation says analytics and AI became essential to balancing affordability, efficiency, and clinical outcomes in India's predominantly self-pay healthcare environment.
Lawmakers, health leaders make bipartisan push to expand clinical trials access
A House Democrat and Republican on Wednesday highlighted their push to expand access to clinical trials, saying artificial intelligence could be one tool used to reach more underrepresented communi…
Common asthma drug helps fight hard-to-treat cancers, including aggressive breast cancers, early study finds
Scientists found that blocking a protein best known for its role in asthma enhances cancer immunotherapy in preclinical models.
NIH awards $50 million to UMass Center for Clinical and Translational Science
The UMass Center for Clinical and Translational Science has been awarded a seven-year, $50 million renewal of its Clinical and Translational Sciences Award.
Advancing care through clinical trials
May 20 is Clinical Trials Day, a time to recognize the importance of clinical research.
Radiologists, other docs quitting clinical practice earlier and for different reasons than before
“Hassle factor” and the profession being “too stressful” were among the top 2 reasons for exiting practice, according to new survey data from the AMA.
Defense Health Network Central rolls out ambient listening technology to enhance patient care
Defense Health Network Central providers are using a new tool to streamline clinical documentation and improve patient-provider interactions.
Sutter Health strengthens maternal care through innovation and connection
Sutter Health is taking a proactive, systemwide approach to maternal care — supporting a range of birth experiences while reinforcing the consistent use of evidence-based practices and clinical protocols.
World Economic Forum: women’s health gets only 20% of R&D funding. We must seize this $1 trillion opportunity
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.
The Women’s Health Innovation Radar:
Advancing women’s health requires not only scientific progress, but an innovation ecosystem capable of translating discovery into evidence, technologies and scalable solutions that improve outcomes for women globally. Yet many high-impact conditions continue to receive insufficient targeted innovation. The Women’s Health Innovation Radar maps activity from research funding and scientific publications to clinical trials and product development across 10 high-impact conditions, highlighting where innovation is advancing and where critical gaps persist. It offers a foundation to guide research priorities, inform policy decisions and mobilize investment towards areas of unmet need, helping to ensure that scientific advances translate into meaningful impact for women worldwide.
The Women’s Health Innovation Radar:
Advancing women’s health requires not only scientific progress, but an innovation ecosystem capable of translating discovery into evidence, technologies and scalable solutions that improve outcomes for women globally. Yet many high-impact conditions continue to receive insufficient targeted innovation. The Women’s Health Innovation Radar maps activity from research funding and scientific publications to clinical trials and product development across 10 high-impact conditions, highlighting where innovation is advancing and where critical gaps persist. It offers a foundation to guide research priorities, inform policy decisions and mobilize investment towards areas of unmet need, helping to ensure that scientific advances translate into meaningful impact for women worldwide.
LSU LCMC Health Cancer Center reshapes healthcare with clinical trials that are at the forefront of medical innovation
For Denise Phipps, a frightening trip to the emergency room for chest pain turned into a diagnosis that could have easily stripped away hope.
Ancient Chinese movement shows promise for reducing blood pressure at home, study says
An ancient Chinese exercise called baduanjin could help lower blood pressure as effectively as some medications, according to a new clinical trial.
Digital Health Technologies for Parental Education in Neonatal Intensive Care Units: Current Evidence and Implications for Nursing Practice
The neonatal intensive care unit (NICU) is a highly complex and emotionally challenging clinical environment, and this situation can make it difficult for parents to interact with their infants ...
Mercer Health earns Numerous National Awards for Excellence in Care
Mercer Health continues to earn national recognition for delivering exceptional healthcare. Multiple prestigious organizations have honored Mercer Health for its outstanding patient experience, clinical excellence, and commitment to quality care. Newsweek Best-In-State Mercer Health has been named one of Newsweek’s Best‑In‑State Hospitals for 2026, a distinction awarded to hospitals that demonstrate superior performance across patient […]
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
Scientists say a daily multivitamin may help slow aging
A daily multivitamin may help slow biological aging, according to researchers studying older adults in a large clinical trial. After two years, participants taking multivitamins showed slower aging in several DNA-based “epigenetic clocks,” with the effect equal to about four months less biological aging. People who started out biologically older than their actual age appeared to benefit the most. The findings hint that a simple supplement could play a role in healthier aging.
AI chatbots and mental health: 4 ways Congress can boost safety
In letters to three key caucuses, the AMA urges lawmakers to establish guardrails that prioritize patient safety, clinical integrity and public trust.
Fera Pets Launches Science-Backed Pet Supplements Into Petco End Caps Nationwide
Fera Pets, the premium veterinarian-founded pet wellness brand known for its science-driven formulations and rigorous quality standards, is expanding into Petco stores nationwide, bringing its clinically-formulated supplements to pet parents in a leading brick-and-mortar retail destination within the space.
Azitra, Inc. Announces Q1 2026 Results and Provides Business Updates
/PRNewswire/ -- Azitra, Inc. ("Azitra" or the "Company") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative...
NAMRU Dayton spotlight: Driving Warfighter Health
Lt. Cmdr. Travis Landry's day-to-day responsibilities at NAMRU Dayton are incredibly diverse. On the clinical side, he maintains his operational skills by conducting submarine and physicals and supporting recruiters heading back to the fleet. Notably, he also provides essential medical care for a large, displaced population of Navy personnel in the Dayton area who are far from traditional Navy Military Treatment Facilities (MTFs)—ensuring that these sailors maintain their readiness even while stationed away from the fleet. On the research side, he plays a critical role in human subject safety. Before any study begins, he evaluates participants to ensure they qualify, reviewing their medical histories and medications to guarantee that the research will cause no harm and that the data collected will be accurate.
Apreo Health® Adds Independent Director and Strategic Investor to Advance Novel Airway Scaffold for Severe Emphysema
Apreo Health, a clinical-stage medical device company pioneering a tissue-sparing treatment for severe emphysema, today announced the appointment of David Amerson to its Board of Directors and a strategic investment from OSF Ventures, the corporate investment arm of OSF HealthCare. The company also announced it will present new clinical data at the American Thoracic Society (ATS) 2026 International Conference in Orlando, Florida.
Alto Neuroscience Reports First Quarter 2026 Financial Results and Recent Business Highlights
MOUNTAIN VIEW, Calif., May 13, 2026--Alto Neuroscience, Inc. ("Alto") (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today reported financial results for the quarter ended March 31, 2026, and highlighted recent progress across its pipeline of clinical-stage product candidates.
Sacramento Kings and Sutter Health Announce Strategic Partnership
Sutter Health to Serve as Official Healthcare and Jersey Patch Partner to Advance Community Health and Clinical Excellence SACRAMENTO, Calif. — Today, the Sacramento Kings and Sutter Health announced a new strategic partnership, uniting two purpose-driven organizations dedicated to community impact, advancing healthy outcomes and long-term investment in the greater Sacramento region. Anchored in Sutter’s […]
Essentia Health-Duluth Clinic welcomes psychotherapist Megan Lexen
Megan Lexen, a licensed independent clinical social worker specializing in psychotherapy, is thrilled to join the Essentia Health-Duluth Clinic.
St. Mary's new Master of Social Work to meet mental health professional shortage
Beginning in Fall 2027, St. Mary’s University will offer a Master of Social Work that will be unique among San Antonio institutions for offering fully asynchronous delivery, Military Social Work and Integrative Behavioral Health Care specializations and an explicitly Marianist values foundation.
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
VANCOUVER, British Columbia, May 11, 2026--AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635
Translating AI Digital Health Into Impact
AI is accelerating digital health, but real impact depends on adoption, collaboration, and integration into clinical care.
Century City Psychiatry Expands Focus on Modern, Evidence-Based Mental Health Innovation and Interventional Psychiatry
/PRNewswire/ -- As mental health care continues to evolve alongside advances in technology, neuroscience, and clinical research, Century City Psychiatry is...
How Flo Health’s Research is Bridging the Knowledge Gap in Women’s Health
Flo’s research efforts are shaped by this reality: focusing on areas where lived, day-to-day health experiences are underrepresented in clinical literature, but deeply consequential in practice.
Health professional schools celebrate commencement, academic milestones - UT Health San Antonio
When the 1,190 spring and summer graduates of The University of Texas at San Antonio’s six health professional schools walk across commencement stages this weekend, they will begin the next chapter of careers and advanced training dedicated to improving health and well-being. The achievement is the culmination of countless hours spent in laboratories and study rooms, lecture halls and clinical spaces.
How Ibasho Support Long-Term Recovery After Disasters?
Belonging, purpose, and community ties through ibasho may be just as vital as clinical care in post-disaster recovery.
How minimum wage hikes and food stamps fit in to suicide prevention
Studies show income, debt and access to basic needs shape mental health outcomes, but U.S. strategies have largely focused on clinical care.
Advancing maternal health: How HCA Healthcare supports moms from pregnancy to postpartum
HCA Healthcare experts explain how we support moms and moms-to-be through education, clinical innovation and compassionate, coordinated care.
Dr. Chloe Carmichael on political breakups destroying American friendships
Clinical psychologist Dr. Chloe Carmichael discusses a study revealing politics destroys American friendships, with Democrats leading in ending relationships.
PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer
First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.
IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights
Advancing next-generation γδ T cell engager platform with initial animal data expected in 2026Reported glioblastoma (GBM) data showing ~97% improvement in progression-free survival vs. standard-of-care; updated median overall survival (mOS) data to be presented at ASCO 2026Hosting R&D Day on May 21, 2026 in New York City NEW YORK, May 07, 2026 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies and γδ
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
BOSTON, May 07, 2026 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced the appointment of Nelson Azoulay as Chief Business Officer. Mr. Azoulay joins Pyxis Oncology with more than 15 years of experience in corporate strategy, business development, and value-creating transactions across the biopharma industry, including deep antibody-drug conjugate (ADC) experience. In his role,
Enliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
/PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and...
Digital health technology offers new hope for better health outcomes
Deborah Estrin was less than a minute into her presentation when she posed the question.“How do we best leverage data from all these digital sources, like wearables and apps and devices, to improve clinical care in patient’s lives?” Estrin asked a crowd of about 200 people at the second annual Arizona Digital Health Symposium.Then, her response.“It’s so much easier said than done,” she said.
Brain health supplements are booming. Here’s what one longevity expert takes.
Only one has been shown in clinical trials to slow cognitive aging, by about two years. This is what the science says about which supplements work.
SPONSORED How health systems navigate patient data with Claude
Health systems are sitting on massive amounts of clinical data, but turning that data into timely patient care isn't always easy.
HealthVerity to Acquire Symphony Health, Uniting Clinical Data and Commercial Analytics to Accelerate Breakthroughs Across the Healthcare Ecosystem
The combined company will join clinical data, commercial analytics and unmatched services into a unified, AI-ready environment to give life sciences organizations a comprehensive, connected view of the patient to move faster from insight to action. HealthVerity HealthVerity Philadelphia, PA, May 05, 2026 (GLOBE NEWSWIRE) -- HealthVerity, Inc., the leader in privacy-protected real-world data exchange and patient identity solutions, today announced that it has entered into a definitive agreement t
Biohaven Reports Recent Business Developments and First Quarter 2026 Financial Results
Biohaven to update clinical, regulatory, and operational progress at annual R&D Day at the upcoming Yale Innovation Summit on May 27, 2026. Advancement of...
InFocus Clinical Research names Elizabeth Nanouris Vice President of Business Operations
InFocus Clinical Research, the only global, full-service retina specialty contract research organization, announced today that Elizabeth Nanouris has joined InFocus as vice president of business operations.
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
Mending Hearts: Danny Romary Turns Struggle Into Service
Discover the inspiring story of Danny, a cardiac survivor who returned to CaroMont Health as a Mended Hearts® volunteer. This story explores the powerful role of peer-to-peer support in heart surgery recovery, highlighting how hope and human connection lead to better clinical outcomes, shorter recovery times, and reduced anxiety. Learn how the Mended Hearts® national nonprofit partners with CaroMont Health to provide emotional support that goes beyond the stethoscope.
Missed Sexual Health Assessment May Limit Clinical Insight
New data show strong links between chronic disease, sexual dysfunction, and loneliness, highlighting missed opportunities for holistic patient evaluation.
New director of Health Information Management joins Trinity
Joe Devlin has joined Trinity Health as director of Health Information Management (HIM), bringing more than a decade of experience to his role, Trinity Health announced. As HIM director, Devlin is responsible for managing the Health Information Management department, including facility and provider coding, clinical documentation and record storage, as well as ensuring compliance with […]
Apotex Gets Health Canada Approval for Generic Semaglutide
Apotex receives Health Canada approval for generic semaglutide injection, matching all commercial formats of Novo Nordisk's Ozempic for type 2 diabetes treatmen
Iterative Health banks $77m to level up AI-driven clinical research tech
Google Ventures-backed Iterative will now expand its platform into burgeoning therapeutic areas like cardiology and obesity.
As artificial intelligence show off diagnostic chops, scientists reckon with the way forward
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical reasoning tasks.
Wave of AI and data science tools set to transform clinical trials
Ahead of Biomed Israel, Ittai Harel highlights a growing cohort of companies leveraging AI and data science tools to revolutionise clinical research.
Iterative Health Closes $77 Million Series C to Accelerate the Future of Clinical Research
Iterative Health closed a $77M Series C funding round led by Intrepid Growth Partners and GV, with participation from new and existing investors.
Radiology vendor Aidoc raises $150M from Goldman Sachs and others
Funding will help the New York-based company expand into additional clinical indications and capabilities while also supporting further development of Aidoc’s CARE Foundation Model.
She set out to become a clinical psychologist. Now she’s leading a US movement to save science
Colette Delawalla launched Stand Up for Science to push back against the Trump’s cuts to medical and scientific research
Cleveland Clinic Establishes Space Health Center
Center aims to broaden research, education and clinical care addressing cardiovascular health conditions related to space travel
Ibogaine Hype Is Outpacing the Science
The hype surrounding the psychedelic drug ibogaine reached a fever pitch earlier this month, when President Donald Trump talked up its potential at a White House event promoting increased access to psychedelics. Ibogaine, which comes from the root of a West African shrub, has long been used for ceremonial and spiritual purposes. Now, for the first time, the Food and Drug Administration will allow a clinical trial of the drug.
Paradigm Health Announces Collaboration with the FDA to Transform Regulatory Review of Clinical Trial Data
/PRNewswire/ -- Today, Paradigm Health announced the launch of a landmark research collaboration with the U.S. Food & Drug Administration (FDA) focused on...
New Verana Health AI Agent Boosts Efficiency and Compliance in MIPS Submissions
/PRNewswire/ -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), has...
Google's clinical director on AI challenges
In this edition of STAT Health Tech newsletter: a conversation with Google's clinical director, an update on Doctronic's Utah experiment, and more.
Neuroinfectious Diseases Research Workshop: Advancing Translational Science and Clinical Innovation
The Neuroinfectious Diseases Research Workshop will be a two-day scientific meeting designed to accelerate research, foster collaboration, and build capacity in the field of neurological infections. Hosted at the NIH Neuroscience Center (NSC, Executive Boulevard), this meeting will bring together clinician-scientists, laboratory investigators, translational researchers, government partners, and trainees committed to advancing understanding of neuroinfectious
Google clinical director says AI can be a ‘bridge’ for people having a mental health crisis
Google's clinical director Megan Bell Jones on how the company is addressing concerns over mental health impacts of its AI products.
Letters: Science as a public duty: What Louisiana is getting right
Louisianians deserve the best science their state can produce, research that reaches into their communities, reflects their lives, and gives back longer lives, better health and real hope. Louisiana’s Clinical
Turn health data into impact: Browns University's online master in biostatistics & health data science
Trained biostatisticians play a central role in clinical science and public health. Brown’s online master’s in biostatistics (health data science concentration), prepares you with a strong foundation in biostatistical and data science methods combined with rigorous training in applied skills to make critical data-driven decisions and meet the growing demand for leaders in this industry – on your schedule
Brain health: Alzheimer's 2026 new report on cognitive impairment & dementia in Tennessee
An estimated 7.4 million Americans age 65 and older are now living with clinical dementia due to Alzheimer's disease, according to a newly released report from
Brain-Gut Health Initiative supports AI-assisted diagnosis of psychiatric disorders
Psychiatric disorders affect millions worldwide, but their diagnosis still relies on clinical observation instead of standard biological tests.